Gastrointestinal Cancer

Top Story

Atezolizumab plus bevacizumab extends survival in unresectable HCC

December 3, 2019
FDA News

FDA grants priority review to pemigatinib for cholangiocarcinoma

November 27, 2019
The FDA granted priority review to pemigatinib for the treatment of patients with previously treated, locally advanced or metastatic cholangiocarcinoma and FGFR2
In the Journals

Omega-3 supplementation fails to reduce risk for colorectal cancer precursors

November 25, 2019
Omega-3 supplementation of 1 g per day did not appear to reduce the risk for colorectal cancer precursors among the average-risk U.S. population, according to results of…
In the Journals

Anal cancer incidence, mortality rise sharply in US

November 25, 2019
Rates of squamous cell carcinoma of the anus and related mortality have risen sharply over the past 15 years, according to results of a retrospective study published in…
More Headlines »
CME

Clinical Advances in Hepatocellular Carcinoma Management – Rapid Response from Chicago

This activity is supported by an educational grant from Merck & Co., Inc.

Hepatocellular carcinoma (HCC) is an aggressive tumor that is commonly diagnosed late in the course of the disease…
More »
Video
Meeting News

VIDEO: BLU-667, avapritinib highlight Blueprint Medicines pipeline

June 13, 2019
More »
Resource Centers
At Issue: Colorectal Cancer Resource Center

At Issue: Colorectal Cancer Resource Center